Concepedia

M. Delforge

MD

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2013

Affiliations

KU Leuven(Current)

M. Delforge is an author at KU Leuven specializing in medicine, radiation oncology, and cell transplantation.

Top concepts

MedicineRadiation OncologyHealthOncologyNeurologyPathologyHematologyOrthopedicsCell TherapyOsteoporosis

Publications per year

2013–2016

3

Publications

3

Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors

Tim Van den Wyngaert, M. Delforge, Chantal Doyen et al. · Supportive Care in Cancer · 2013 · 25 citations

Treatment Pattern, Surgical Oncology, Zoledronic Acid Therapy +8

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

Bouke P. C. Hazenberg, Alexandra Croockewit, Bronno van der Holt et al. · Haematologica · 2015 · 22 citations · Full text

Cell Therapy, Solid Organ Transplantation, Extended Survival +18

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma

K. Weisel, Meletios Α. Dimopoulos, Philippe Moreau et al. · Haematologica · 2016 · 20 citations · Full text

Rows per page

1–3 of 3